Just before the 23andMe SPAC deal closed, the stock belonging to its merger ... giving investors the impression it is a ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.

Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

and the FTC has issued letters stressing potential risks to U.S. bankruptcy trustees. 23andMe, which was founded in 2006, has collected DNA and associated genetic material on seven million ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Elicit Brewing Co. is expected to open for business in the former Barnes & Noble space in ... also made a $300 million equity investment in 23andMe. When 23andMe went public in 2021, its ...

DNA-testing company 23andMe has filed for bankruptcy, which means the future of the company’s vast trove of customer data is ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...